跳至主要内容
临床试验/NCT02927600
NCT02927600已完成不适用

Impact of Low Glycemic Responses Breakfast or Dinner on Postprandial Glycemia of the Subsequent Meals

Société des Produits Nestlé (SPN)2 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2016年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
48
试验地点
2
主要终点
Glycemia

研究概览

简要总结

The primary objective is to determine which among high vs low Glycemic Index (GI) / Glycemic Responses (GR) interventions at breakfast or at dinner is the most effective for lowering glycemic response of the subsequent standard meal.

详细描述

Consumption of low Glycemic Index (GI) foods has been shown to not only attenuate blood glucose response during the postprandial period immediately following a meal but to have also positive metabolic effects at the subsequent meal, known as the "second-meal effect" by reducing glucose excursion beyond actual meal. The relative importance of the timing of the glycemic load variation (e.g., breakfast or dinner) on the overall, 24h, glycemic control has not been investigated in detail.

We hypothesize that eating low GI foods in a single meal either for breakfast or for dinner would have different consequential effects on glycemic control over the following meal and thereafter during 24 hours. In order to establish the relative importance of breakfast or dinner in predicting glycemic control/response of the following meal and for a 24-hour period this study will use comprehensive methods including Continuous Glucose Monitoring Systems (CGMS) as well as measuring postprandial blood glucose and insulin.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
None

入排标准

年龄范围
50 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 50 to ≤ 70 years old years
  • Chinese male and female healthy subjects having both grandparents Chinese
  • Body mass index: ≥ 18.5 to ≤ 24.9kg/m2
  • Waist circumference ≤90 cm for males and ≤ 85 cm for females
  • Systolic blood pressure <150 mmHg; Diastolic blood pressure <90 mmHg
  • Willing and able to sign written informed consent prior to trial entry

排除标准

  • Known Diabetes type 2, under medication
  • Fasting Glycemia > 7 mmol/L
  • Any clinically relevant gastrointestinal (ulcer, malabsorption), renal (insufficiency), cardiovascular (stroke, arterial hypertension, heart disease), metabolic disease (dyslipidemia), psychiatric disorder (depression) that would affect the study in the opinion of the CNRC clinician, according to a detailed medical history and a blood sampling at screening, only if deemed necessary by CNRC clinician.
  • Anemia (anamnesis)
  • Subjects who had a history of major gastrointestinal surgery
  • Subjects who had more than 5% weight loss from baseline weight during the past three months (more than 5% of initial weight)
  • Present drug abuse or use of medications that could interfere with the treatment or energetic metabolism including corticosteroids, growth hormone, hormonal replacement therapy, anti-hypertensives like ACE inhibitor, thiazides and angiotensin receptors blockers. These conditions will be screened based on subject reporting. Participants will be asked to bring in their current medications at the time of screening, and these will be checked by the study-staff.
  • Subject allergic /intolerant to any of the test foods or any of the following common food and ingredients: eggs, fish, milk, peanuts, and tree nuts, shellfish, soya, wheat, gluten, cereal, fruits, dairy products, meat, vegetable, sugar and sweetener, natural food colourings or flavourings etc.
  • Subject on special diets especially vegetarian, high protein or weight loss program.
  • Current smokers (i.e. people having smoked in the month preceding the enrolment)
  • Subjects having a high alcohol consumption (more than 2 drinks/day)
  • Subjects who are not willing and not able to comply with scheduled visits and the requirements of the study procedures in the opinion of the investigators.
  • Currently participating or having participated in another clinical trial within 4 weeks prior to trial start.

研究组 & 干预措施

Low GI Rice Breakfast

Experimental

Intake of low GI breakfast

干预措施: Low GI Breakfast (Other)

High GI rice Breakfast

Experimental

Intake of High GI breakfast

干预措施: High GI Breakfast (Other)

Low GI Rice Dinner

Experimental

Intake of low GI dinner

干预措施: Low GI Dinner (Other)

High GI Rice Dinner

Experimental

Intake of High GI dinner

干预措施: High GI Dinner (Other)

结局指标

主要结局

Glycemia

时间窗: 3 hours

Incremental areas under curve (iAUC) of glycemia in the 3 hours following meal intake

次要结局

  • Glycemia(24h)
  • Plasma glucagon(3 hours)
  • Plasma insulin(3 hours post meal intake)
  • Plasma triglycerides(3 hours post meal intake)
  • Hunger(Every 30 minutes over the 3 hours post meal intake)
  • Plasma glycerol(3 hours post meal intake)
  • Plasma free fatty acids(3 hours)
  • Satiety(Every 30 minutes over the 3 hours post meal intake)

研究者

发起方
Société des Produits Nestlé (SPN)
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验